View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 18, 2024
1 min read
Save

FDA grants 510(k) clearance to stereotactic guidance system for neurosurgery

FDA grants 510(k) clearance to stereotactic guidance system for neurosurgery

The FDA has granted 510(k) clearance to a gene therapy-enabling company for a system that aims for greater accuracy in the placement and operation of instruments or devices in procedures for neurological conditions.

SPONSORED CONTENT
January 18, 2024
2 min read
Save

No significant readmission risk across subtypes for older adults hospitalized for stroke

No significant readmission risk across subtypes for older adults hospitalized for stroke

In a cohort of older adults hospitalized for an initial stroke, readmission risk was not significantly different among stroke subtypes or over different time intervals, according to research published in Neurology.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
January 17, 2024
3 min read
Save

CMS finalizes rule streamlining, digitizing prior authorization process

CMS finalizes rule streamlining, digitizing prior authorization process

CMS has finalized a new final rule that aims to shorten prior authorization timelines and streamline processes to remove barriers to patient care, according to a press release.

SPONSORED CONTENT
January 17, 2024
2 min read
Save

International medical graduate shares perspective on US residency

International medical graduate shares perspective on US residency

“Is it all worth it?” reads the title of the Reddit post from an international medical graduate community. I wake up to these posts ever so frequently; I think to myself and slide the notification away.

SPONSORED CONTENT
January 17, 2024
1 min read
Save

FDA grants rare pediatric disease designation to alpha kinase inhibitor for ROSAH syndrome

FDA grants rare pediatric disease designation to alpha kinase inhibitor for ROSAH syndrome

The FDA has granted rare pediatric disease designation to an alpha-kinase 1 inhibitor to treat patients with retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis and headache, or ROSAH, syndrome.

SPONSORED CONTENT
January 16, 2024
1 min read
Save

FDA approves Hyqvia for chronic inflammatory demyelinating polyneuropathy

FDA approves Hyqvia for chronic inflammatory demyelinating polyneuropathy

The FDA has approved Takeda Pharmaceutical’s Hyqvia, coformulated with Halozyme's Enhanze drug delivery technology, to treat chronic inflammatory demyelinating polyneuropathy in adults.

SPONSORED CONTENT
January 16, 2024
1 min read
Save

Biotech firm receives $24M to develop neurorestorative therapies

Biotech firm receives $24M to develop neurorestorative therapies

A Boston-area biotech company has received $24 million in Series A funding to develop neurorestorative and remyelinating therapies for a broad range of neurological conditions.

SPONSORED CONTENT
January 14, 2024
2 min read
Save

‘Get there first’ to reduce the chance of a whistleblower

‘Get there first’ to reduce the chance of a whistleblower

WAILEA, Hawaii — Health care law trends in 2023 were telehealth, whistleblowers, physician referrals and a more intense focus on compliance by providers and practices, according to a law expert speaking at Hawaiian Eye/Retina 2024.

SPONSORED CONTENT
January 12, 2024
2 min read
Save

Recent migraine diagnosis linked to increased risk for car crashes among older drivers

Recent migraine diagnosis linked to increased risk for car crashes among older drivers

Older adults recently diagnosed with migraine were more than three times likely to be involved in a motor vehicle crash within a year compared with those who never had a migraine diagnosis, according to researchers.

SPONSORED CONTENT
January 12, 2024
2 min read
Save

Degree of cognitive impairment after 6 months dependent on TBI severity

Degree of cognitive impairment after 6 months dependent on TBI severity

In a cohort of adults with traumatic brain injury, level of impairment for those who exhibited cognitive impairment after 6 months was directly correlated to TBI severity, according to research from JAMA Network Open.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails